HFA Premium Access

Elamipretide in heart failure with reduced ejection fraction.

Topic: Cell Signalling
Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Stealth Peptides

Congress Presentation

About the speaker

Professor Hani Sabbah

Henry Ford Hospital, Detroit (United States of America)
3 presentations
0 follower

3 more presentations in this session

Reaching the next level of drug development for heart failure: targetting mitochondria.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Elamipretide improves mitochondrial activity in the failing human heart.

Speaker: Doctor B. Stauffer (Aurora, US)

Thumbnail

Clinical development concepts targeting mitochondria.

Speaker: Professor B. Pitt (Ann Arbor, US)

Thumbnail

Access the full session

Targeting mitochondria to improve outcomes in heart failure

Speakers: Professor H. Sabbah, Professor S. Anker, Doctor B. Stauffer, Professor B. Pitt
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by